SG139553A1 - 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof - Google Patents
7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereofInfo
- Publication number
- SG139553A1 SG139553A1 SG200602066-3A SG200602066A SG139553A1 SG 139553 A1 SG139553 A1 SG 139553A1 SG 200602066 A SG200602066 A SG 200602066A SG 139553 A1 SG139553 A1 SG 139553A1
- Authority
- SG
- Singapore
- Prior art keywords
- enoic
- hept
- derivatives
- substituted
- heptanoic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
- C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25747588A | 1988-10-13 | 1988-10-13 | |
| US35553189A | 1989-05-22 | 1989-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG139553A1 true SG139553A1 (en) | 2008-02-29 |
Family
ID=26945992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200602066-3A SG139553A1 (en) | 1988-10-13 | 1989-10-11 | 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof |
Country Status (24)
| Country | Link |
|---|---|
| EP (2) | EP0363934B1 (fi) |
| JP (1) | JP2853227B2 (fi) |
| KR (1) | KR0162656B1 (fi) |
| AT (1) | ATE99281T1 (fi) |
| AU (1) | AU636122B2 (fi) |
| BG (1) | BG60555B1 (fi) |
| CA (1) | CA2000553C (fi) |
| CZ (1) | CZ283316B6 (fi) |
| DE (1) | DE68911834T2 (fi) |
| DK (1) | DK175073B1 (fi) |
| ES (1) | ES2060712T3 (fi) |
| FI (1) | FI98063C (fi) |
| HK (1) | HK49496A (fi) |
| HU (1) | HU207993B (fi) |
| IE (2) | IE940109L (fi) |
| IL (1) | IL91941A (fi) |
| MY (1) | MY105067A (fi) |
| NO (1) | NO174623C (fi) |
| NZ (1) | NZ230973A (fi) |
| RO (1) | RO109732B1 (fi) |
| SG (1) | SG139553A1 (fi) |
| SK (1) | SK280845B6 (fi) |
| WO (1) | WO1990003962A1 (fi) |
| YU (1) | YU48466B (fi) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118853A (en) * | 1988-10-13 | 1992-06-02 | Sandoz Ltd. | Processes for the synthesis of 3-disubstituted aminoacroleins |
| US5290946A (en) * | 1988-10-13 | 1994-03-01 | Sandoz Ltd. | Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes |
| CA2027179A1 (en) * | 1989-10-10 | 1991-04-11 | Barry C. Ross | Chemical compounds |
| DE4424525A1 (de) * | 1994-07-12 | 1995-01-26 | Elmar Meyer | Dauermagnet-Kolbenmotor |
| GT199800127A (es) | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. | |
| DE60022525T2 (de) | 1999-08-30 | 2006-06-14 | Sanofi Aventis Deutschland | Ramipril zur vorbeugung von kardiovaskulären vorfällen |
| US6743926B2 (en) | 2000-05-26 | 2004-06-01 | Ciba Specialty Chemicals Corporation | Process for the preparation of indole derivatives and intermediates of the process |
| US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
| JPWO2004094377A1 (ja) * | 2003-04-24 | 2006-07-13 | ダイセル化学工業株式会社 | 光学活性なジヒドロキシヘプテン酸エステルの分離方法 |
| KR20070092993A (ko) | 2003-06-18 | 2007-09-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 플루바스타틴 나트륨 결정형 ｘｉｖ, ｌｘｘｉｉｉ,ｌｘｘｉｘ, ｌｘｘｘ 및 ｌｘｘｘｖｉｉ, 이의 제조 방법,이를 포함하는 조성물 및 이를 사용하는 방법 |
| US7368468B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| WO2005053683A1 (en) | 2003-11-26 | 2005-06-16 | Duke University | A method of preventing or treating glaucoma |
| US7851624B2 (en) | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ES2327668T3 (es) | 2006-04-20 | 2009-11-02 | F.I.S. Fabbrica Italiana Sintetici S.P.A. | Procedimiento para la preparacion de sal sodica de fluvastatina. |
| WO2010069593A1 (en) | 2008-12-19 | 2010-06-24 | Krka, D. D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| EP2327682A1 (en) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| WO2013113067A1 (en) | 2012-02-02 | 2013-08-08 | The University Of Sydney | Improvements in tear film stability |
| JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| JOP20210193A1 (ar) | 2019-01-18 | 2023-01-30 | Astrazeneca Ab | مثبطات pcsk9 وطرق استخدامها |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB945536A (en) * | 1961-09-08 | 1964-01-02 | Istituto Chemioterapico | Method of preparing ª -amino-acroleins |
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| AU570021B2 (en) * | 1982-11-22 | 1988-03-03 | Novartis Ag | Analogs of mevalolactone |
| US4571428A (en) * | 1983-07-08 | 1986-02-18 | Sandoz, Inc. | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones |
| US4650890A (en) * | 1984-04-03 | 1987-03-17 | Sandoz Corp. | Preparation of olefinic compounds and intermediates thereof |
| WO1986000307A2 (en) * | 1984-06-22 | 1986-01-16 | Sandoz Ag | Pyrazole analogs of mevalonolactone and derivatives thereof, processes for their production and their use |
| KR910003427B1 (ko) * | 1984-12-04 | 1991-05-31 | 산도즈 파마슈티칼스 코포레이션 | 메발로노락톤의 인덴동족체 및 이들의 유도체의 제법 |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| EP0244364A3 (en) * | 1986-04-30 | 1992-04-01 | Sandoz Ag | Preparation of olefinic compounds |
| PT85662B (pt) * | 1986-09-10 | 1990-06-29 | Sandoz Sa | Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem |
-
1989
- 1989-10-11 JP JP1510605A patent/JP2853227B2/ja not_active Expired - Lifetime
- 1989-10-11 HU HU896048A patent/HU207993B/hu unknown
- 1989-10-11 AU AU43448/89A patent/AU636122B2/en not_active Expired
- 1989-10-11 EP EP89118906A patent/EP0363934B1/en not_active Expired - Lifetime
- 1989-10-11 IE IE940109A patent/IE940109L/xx unknown
- 1989-10-11 YU YU197389A patent/YU48466B/sh unknown
- 1989-10-11 EP EP19930106005 patent/EP0562643A3/en not_active Ceased
- 1989-10-11 MY MYPI89001403A patent/MY105067A/en unknown
- 1989-10-11 IE IE327789A patent/IE63477B1/en not_active IP Right Cessation
- 1989-10-11 NZ NZ230973A patent/NZ230973A/xx unknown
- 1989-10-11 ES ES89118906T patent/ES2060712T3/es not_active Expired - Lifetime
- 1989-10-11 KR KR1019900701243A patent/KR0162656B1/ko not_active IP Right Cessation
- 1989-10-11 SG SG200602066-3A patent/SG139553A1/en unknown
- 1989-10-11 WO PCT/EP1989/001201 patent/WO1990003962A1/en active IP Right Grant
- 1989-10-11 RO RO145326A patent/RO109732B1/ro unknown
- 1989-10-11 AT AT89118906T patent/ATE99281T1/de not_active IP Right Cessation
- 1989-10-11 IL IL9194189A patent/IL91941A/en not_active IP Right Cessation
- 1989-10-11 DE DE68911834T patent/DE68911834T2/de not_active Expired - Lifetime
- 1989-10-12 CZ CS895797A patent/CZ283316B6/cs not_active IP Right Cessation
- 1989-10-12 SK SK5797-89A patent/SK280845B6/sk unknown
- 1989-10-12 CA CA002000553A patent/CA2000553C/en not_active Expired - Lifetime
-
1990
- 1990-06-07 BG BG92179A patent/BG60555B1/bg unknown
- 1990-06-12 NO NO902598A patent/NO174623C/no unknown
- 1990-06-12 FI FI902935A patent/FI98063C/fi active IP Right Grant
- 1990-06-13 DK DK199001446A patent/DK175073B1/da not_active IP Right Cessation
-
1996
- 1996-03-21 HK HK49496A patent/HK49496A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG139553A1 (en) | 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof | |
| EP0406428A4 (en) | Peptide derivatives and their use | |
| GB2210043B (en) | Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides | |
| EP0343364A3 (en) | Positioning and press-sealing means | |
| AU2999192A (en) | Anti-atherogenic agents | |
| US5036098B1 (en) | Butynlamine derivatives and their production | |
| GB2333292B (en) | Derivatives of hexaazoisowurtzitane | |
| GB2217134B (en) | Amplifier | |
| EP0313969A3 (en) | Tripeptide derivatives and antiplasmin agents containing the same | |
| GB8826026D0 (en) | Modified v i improvers | |
| AU5606586A (en) | Pseudopterosin and derivatives | |
| AU564013B2 (en) | 1,8-bridged 4-quinolone-3-carboxylic acids and derivatives | |
| EP0353742A3 (en) | Amplifier | |
| EP0311329A3 (en) | Optically active-1-(2-halogen-substituted-phenyl)-ethanols and derivatives thereof | |
| GB8802421D0 (en) | Set of parts | |
| JPS6470453A (en) | 2-hydroxybenzophenonehydrazide and derivative | |
| AU4511989A (en) | Article based on fur of natural origin | |
| EP0318254A3 (en) | Tripeptide derivatives | |
| IL92606A0 (en) | Sphingenine and derivatives thereof | |
| SG63583A1 (en) | 7-substituted-hept-6-enoic and - heptanoic acids and derivatives thereof | |
| EP0435265A3 (en) | Unsaturated polylactones and derivatives thereof | |
| HK79794A (en) | Current source technology | |
| GR3020041T3 (en) | Aminocarboxylic acids and derivatives thereof | |
| IL82458A (en) | Derivatives based upon pyrido-menadione adducts and uses thereof | |
| ZA901443B (en) | Aminoethylthiazole and aminoethyloxazole derivatives |